Skip to main content
RSC Drug Discovery Series

Chapter 14: Active Learning for Drug Discovery and Automated Data Curation

Publication ,  Chapter
Reker, D
January 1, 2021

Active machine learning is an experimental design approach that puts machine learning models in the driver seat of data acquisition and automated optimization. Introduced to drug discovery approximately 15 years ago, a handful of impressive studies have revealed the potential of active machine learning to guide molecular discovery and optimization. Most recently, researchers have shown that active learning can also be applied to datasets retrospectively, enabling automated data curation to train powerful machine learning models on small datasets. This chapter reviews the key findings from these active learning studies and summarizes remaining challenges and future opportunities of active learning as an adaptive learning technology in the context of drug discovery.

Duke Scholars

DOI

Publication Date

January 1, 2021

Volume

2021-January

Start / End Page

301 / 326
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Reker, D. (2021). Chapter 14: Active Learning for Drug Discovery and Automated Data Curation. In RSC Drug Discovery Series (Vol. 2021-January, pp. 301–326). https://doi.org/10.1039/9781788016841-00301
Reker, D. “Chapter 14: Active Learning for Drug Discovery and Automated Data Curation.” In RSC Drug Discovery Series, 2021-January:301–26, 2021. https://doi.org/10.1039/9781788016841-00301.
Reker D. Chapter 14: Active Learning for Drug Discovery and Automated Data Curation. In: RSC Drug Discovery Series. 2021. p. 301–26.
Reker, D. “Chapter 14: Active Learning for Drug Discovery and Automated Data Curation.” RSC Drug Discovery Series, vol. 2021-January, 2021, pp. 301–26. Scopus, doi:10.1039/9781788016841-00301.
Reker D. Chapter 14: Active Learning for Drug Discovery and Automated Data Curation. RSC Drug Discovery Series. 2021. p. 301–326.

DOI

Publication Date

January 1, 2021

Volume

2021-January

Start / End Page

301 / 326